Medical, social, and economic perspectives of health care development. Prostate Cancer Early Diagnosis and Screening Program
- Authors: Leonova A.O.1, Kopyltsov E.I.1,2, Alekseev B.Y.3,4, Sikhvardt I.A.1,2, Yurgel Y.N.1, Leonov O.V.1,2, Vodolazskiy V.A.1, Durnev I.A.1
-
Affiliations:
- Omsk Clinical Oncological Dispensary
- Siberian State University of Physical Education and Sports
- P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
- Medical Institute of Continuing Education, Moscow State University of Food Production
- Issue: Vol 18, No 2 (2022)
- Pages: 217-225
- Section: TOPICAL PROBLEM
- Published: 15.08.2022
- URL: https://oncourology.abvpress.ru/oncur/article/view/1524
- DOI: https://doi.org/10.17650/1726-9776-2022-18-2-217-225
- ID: 1524
Cite item
Full Text
Abstract
Aim. To improve diagnostics and screening of prostate cancer to ensure early detection of malignant tumors.
Materials and methods. We analyzed the population size and structure in the region in 2005–2010. The primary diagnostics of prostate cancer in regional healthcare institutions allowed the detection of locally advanced tumors and generalized cancer. Such diagnostic approaches can produce only accidental diagnosis since they lack proper systematization, organization, and control.
Results. We have developed and implemented into clinical practice a long-term Program for Prostate Cancer Early Diagnosis and Screening. It includes a diagnostic algorithm for prostate cancer that was modified for clinical use. Screening starts with the PSA blood test performed annually. Patients with PSA level >10 ng/mL should undergo additional diagnostic procedures. The Program implies active use of currently available information technologies to implement a unified routing scheme for cancer patients, execute measures for early cancer diagnosis, and warrant promptness and reliability of the cancer registry.
Conclusion. Implementation of the long-term Program for Prostate Cancer Early Diagnosis and Screening will help to improve prostate cancer diagnosis, and, therefore, treatment outcomes.
Keywords
About the authors
A. O. Leonova
Omsk Clinical Oncological Dispensary
Email: leonova_stusha@mail.ru
ORCID iD: 0000-0001-9938-7038
Build. 1, 9 Zavertyaeva St., Omsk 644013
Russian FederationE. I. Kopyltsov
Omsk Clinical Oncological Dispensary; Siberian State University of Physical Education and Sports
Email: kopyltsov_evgen@mail.ru
ORCID iD: 0000-0003-3165-9118
Build. 1, 9 Zavertyaeva St., Omsk 644013; 144 Maslennikova St., Omsk 644009
Russian FederationB. Ya. Alekseev
P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia; Medical Institute of Continuing Education, Moscow State University of Food Production
Email: byalekseev@mail.ru
ORCID iD: 0000-0002-3398-4128
3 2nd Botkinskiy Proezd, Moscow 125284; 11 Volokolamskoe Shosse, Moscow 125080
Russian FederationI. A. Sikhvardt
Omsk Clinical Oncological Dispensary; Siberian State University of Physical Education and Sports
Email: ivan_sichv@mail.ru
ORCID iD: 0000-0001-9072-7702
Build. 1, 9 Zavertyaeva St., Omsk 644013; 144 Maslennikova St., Omsk 644009
Russian FederationYu. N. Yurgel
Omsk Clinical Oncological Dispensary
Email: yurgel.yn@gmail.com
ORCID iD: 0000-0002-9845-9383
Build. 1, 9 Zavertyaeva St., Omsk 644013
Russian FederationO. V. Leonov
Omsk Clinical Oncological Dispensary; Siberian State University of Physical Education and Sports
Author for correspondence.
Email: leonov_oleg@mail.ru
ORCID iD: 0000-0001-6667-7135
Oleg Vladimirovich Leonov
Build. 1, 9 Zavertyaeva St., Omsk 644013; 144 Maslennikova St., Omsk 644009
Russian FederationV. A. Vodolazskiy
Omsk Clinical Oncological Dispensary
Email: vod_vlad@mail.ru
ORCID iD: 0000-0002-6839-5411
Build. 1, 9 Zavertyaeva St., Omsk 644013
Russian FederationI. A. Durnev
Omsk Clinical Oncological Dispensary
Email: spartadoc11@gmail.com
ORCID iD: 0000-0002-4958-388X
Build. 1, 9 Zavertyaeva St., Omsk 644013
Russian FederationReferences
- Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization, 2014. 114 р.
- Taitt H.E. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health 2018;12(6):1807–23. doi: 10.1177/1557988318798279
- Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70(1):7–30. DOI: 10.3322 / caac.21590
- Rawla P. Epidemiology of prostate cancer. World J Oncol 2019;10(2):63–89. doi: 10.14740/wjon1191
- State of oncological care in Russia in 2010. Eds.: V.I. Chissov, V.V. Starinskiy, G.V. Petrova. Moscow: FGU “MNIOI im. P.A. Gertsena” Minzdravsotsrazvitiya Rossii, 2011. 188 p. (In Russ.).
- Vickers A.J. Prediction models in cancer care. CA Cancer J Clin 2011;61(5):315–26. doi: 10.3322/caac.20118
- State of oncological care in Russia in 2012. Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: FGBU “MNIOI im. P.A. Gertsena” Minzdrava Rossii, 2013. 231 p. (In Russ.).
- Guide to cancer early diagnosis. Geneva: World Health Organization, 2018. 38 р. 9. Bray F., Ferley F., Soerjomataram I. et. al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–24. doi: 10.3322/caac.21492
- Rundle A., Neckerman K.M., Sheehan D. et al. A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer. Cancer Causes Control 2013;24(2):297–303. doi: 10.1007/s1055201201086
- Axel E.M., Matveev V.B. Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR. Onkourologiya = Cancer Urology 2019;15(2):15–24. (In Russ.). doi: 10.17650/17269776 20191521524
- Patel N.H., Bloom J., Hillelsohn J. et al. Prostate cancer screening trends after United States preventative services task force guidelines in an underserved population. Health Equity 2018;2(1): 55–61. doi: 10.1089/heq.2018.0004
- Carter H.B., Albertsen P.C., Barry M.J. et al. Early detection of prostate cancer: AUA Guideline. J Urol 2013;190(2):419–26. doi: 10.1016/j.juro.2013.04.119
- Hsing A.W., Chokkalingam A.P. Prostate cancer epidemiology. Front Biosci 2006;11: 1388–413. doi: 10.2741/1891
- Postma R., Schröder F.H., van Leenders G.J.L.H. et. al. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) – section Rotterdam. A comparison of two rounds of screening. Eur Urol 2007;52(1):89–97. doi: 10.1016/j.eururo.2007.01.030
- Preventive Services Task Force (Moyer Va. U.S.). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157(2):120–34. doi: 10.7326/00034819157220120717000459
- Brett A.S., Ablin R.J. Prostatecancer screening – what the US Preventive Services Task Force left out. N Engl J Med 2011;365(21):1949–51. doi: 10.1056/NEJMp1112191
- Fenton J.J., Weyrich M.S., Durbin S. et al. Prostatespecific antigenbased screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2018;319(18):1914–31. doi: 10.1001/jama.2018.3712
- Zhuravlev V.N., Bazhenov I.V., Zyryanov A.V. et al. Organization of early diagnosis of oncourological diseases in the Sverdlovsk region. Onkourologiya = Cancer Urology 2009;5(1):71–5. (In Russ.).
- Engalychev F.S., Mironov M.A., Galkina N.G. et al. Results of a goaloriented prostate cancer screening program in the Penza region. Onkourologiya = Cancer Urology 2012;8(1):62–5. (In Russ.).
- Krasnyi S.A., Tarend D.T., Semenov S.A. The results of prostate cancer screening and the problem of the hyperdiagnosis of the disease in the Republic of Belarus. Onkourologiya = Cancer Urology 2016; 12(1):58–62. (In Russ.). doi: 10.17650/1726977620161215862
- Vazhenin A.V., Karnaukh P.A., Kipriyanov E.A. et al. Early diagnosis of prostate cancer on the example of the contingent of employees of an enterprise in the Russian Federation. Tyumenskiy meditsinskiy zhurnal = Tyumen Medical Journal 2015;17(3): 16–9. (In Russ.)
- Heidenreich A., Abrahamsson P.A., Artibani W. et al. Early detection of prostate cancer: European Association of Urology Recommendation. Eur Urol 2013;64(3):347–54. doi: 10.1016/j.eururo.2013.06.051
- Danilov A.I., Bizenkov A.S. Health care system reforming in modern Russia. Vestnik Smolenskoy gosudarstvennoy meditsinskoy akademii = Bulletin of the Smolensk State Medical Academy 2019;18(1):202–5. (In Russ.).
- Novikov D.A. The theory of management of organizational systems. 2nd edn. Moscow: Fizmatlit, 2007. 584 р. (In Russ.).
- Spurgeon P., Mazelan P., Barwell F. A management control approach to monitor largescale change: an illustration in the context of reconfiguration. Health Serv Manage Res 2011;24(1):19–28. doi: 10.1258/hsmr.2010.010010
- Organization personnel management. Ed.: A.Ya. Kibanov. Moscow: InfraM, 2011. 304 р. (In Russ.).
- Shapiro S.A., Shataeva O.V. Fundamentals of human resource management in modern organizations. Moscow: GrossMedia, ROSBUKH, 2008. 468 р. (In Russ.).
- Decree of the Government of the Omsk Region dated July 19, 2010 № 140п “On the approval of the longterm target program of the Omsk Region “Regional project “Oncology” for 2011–2015”. (In Russ.).
Supplementary files

